Oligohydrosis underestimated side effect with topiramate treatment [1]

Indian Journal of Pediatrics

Volumn 74, Issue 7, 2007, Pages 694-

  Fung, Eva L W ^a   Nelson, Edmund A S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; TOPIRAMATE; DRUG DERIVATIVE; FRUCTOSE;

CASE REPORT; DRUG DOSE INCREASE; DRUG TOLERABILITY; EPILEPSY; FOCAL EPILEPSY; HUMAN; LETTER; MALE; OLIGOHYDROSIS; SCHOOL CHILD; SEDATION; SWEAT GLAND DISEASE; TREATMENT DURATION; ANHIDROSIS; CHEMICALLY INDUCED DISORDER; CHILD;

ANTICONVULSANTS; CHILD; EPILEPSIES, PARTIAL; FRUCTOSE; HUMANS; HYPOHIDROSIS; MALE;

EID: 34548644504     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-007-0124-9     Document Type: Letter

References (6)

1. Arcas J, Ferrer T, Roche MC et al. Hypohidrosis related to the administration of topiramate to children. Epilepsia 2001; 42: 1363-1365.
2. Ben Zeev B, Watemberg N, Augarten A et al. Oligohydrosis and hyperthermia: pilot study of a novel topiramate adverse effect. J Child Neurol 2003; 18: 254-257.
3. de Carolis P, Magnifico F, Pierangeli G et al. Transient hypohidrosis induced by topiramate. Epilepsia 2003; 44: 974-976.
4. Ziad eK, Rahi AC, Hamdan SA et al. Age, dose, and environmental temperature are risk factors for topiramate-related hyperthermia. Neurology 2005, 65: 1139-1140.
5. Cerminara C, Seri S, Bombardieri R et al. Hypohidrosis during topiramate treatment: a rare and reversible side effect. Pediatr Neurol 2006; 34: 392-394.
6. Galicia SC, Lewis SL, Metman LV. Severe topiramate-associated hyperthermia resulting in persistent neurological dysfunction. Clin Neuropharmacol 2005; 28: 94-95.